Literature DB >> 1717286

Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone.

T B McCall1, R M Palmer, S Moncada.   

Abstract

Rat peritoneal polymorphonuclear leukocytes (PMN) elicited with oyster glycogen contain a Ca(2+)-independent nitric oxide (NO) synthase which is induced in vivo in a time-dependent manner. When washed PMN containing low levels of enzyme activity were cultured ex vivo further expression of NO synthase was observed. This was inhibited by cycloheximide indicating that de novo synthesis of the enzyme occurred during the ex vivo incubation. Enzyme activity was enhanced by interferon (IFN)-gamma, but not by tumor necrosis factor (TNF)-alpha when added ex vivo. However, IFN-gamma and TNF-alpha synergized to increase further the expression of NO synthase. Treatment of rats with dexamethasone inhibited the induction of NO synthase in elicited PMN. This treatment reduced the accumulation of PMN by approximately 30%, without affecting cell viability. Dexamethasone also inhibited the induction of the NO synthase ex vivo in a concentration-dependent manner. Furthermore, the enhanced enzyme activity following treatment of PMN with cytokines was also inhibited by dexamethasone. Once induced, dexamethasone did not affect enzyme activity. These data indicate that PMN elicited in the rat peritoneum with oyster glycogen express an NO synthase in vivo and ex vivo. The induction of the enzyme can be further stimulated ex vivo with IFN-gamma and TNF-alpha and inhibited by dexamethasone. The inhibition of the induction of NO synthase in the PMN by dexamethasone may contribute to the anti-inflammatory activity of this and other glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717286     DOI: 10.1002/eji.1830211032

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  31 in total

1.  More on pathogenesis and treatment of septic shock.

Authors:  D Fumarola; S Pece
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

Review 2.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

3.  Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria.

Authors:  T J Evans; L D Buttery; A Carpenter; D R Springall; J M Polak; J Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

4.  Kinetic evaluation of nitric oxide production in pleural exudate after induction of two inflammatory reactions in the rat.

Authors:  C Regnault; M Roch-Arveiller; I Florentin; J P Giroud; E Postaire; M Delaforge
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

5.  Nuclear factor kappaB is required for the transcriptional control of type II NO synthase in regenerating liver.

Authors:  M J Díaz-Guerra; M Velasco; P Martín-Sanz; L Boscá
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Nitric oxide-generating system as an autocrine mechanism in human polymorphonuclear leucocytes.

Authors:  A Riesco; C Caramelo; G Blum; M Montón; M J Gallego; S Casado; A López Farré
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

7.  Involvement of nitric oxide synthase in the delayed vasodilator response to ultraviolet light irradiation of rat skin in vivo.

Authors:  J B Warren; R K Loi; M L Coughlan
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Attenuation of acute inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G.

Authors:  J M Antonini; K van Dyke; M DiMatteo; M J Reasor
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

Review 9.  Myeloperoxidase: a front-line defender against phagocytosed microorganisms.

Authors:  Seymour J Klebanoff; Anthony J Kettle; Henry Rosen; Christine C Winterbourn; William M Nauseef
Journal:  J Leukoc Biol       Date:  2012-10-11       Impact factor: 4.962

10.  Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.

Authors:  Deyan Luo; Jr-Shiuan Lin; Michelle A Parent; Isis Mullarky-Kanevsky; Frank M Szaba; Lawrence W Kummer; Debra K Duso; Michael Tighe; Jim Hill; Andras Gruber; Nigel Mackman; David Gailani; Stephen T Smiley
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.